These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
575 related articles for article (PubMed ID: 32005248)
1. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis. Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248 [TBL] [Abstract][Full Text] [Related]
2. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459 [TBL] [Abstract][Full Text] [Related]
3. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
4. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367 [TBL] [Abstract][Full Text] [Related]
5. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature. Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma. Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814 [TBL] [Abstract][Full Text] [Related]
8. Identification of m Ma Y; Sun Y; Zhao X; Li J; Fu X; Gong T; Zhang X Sci Rep; 2023 Sep; 13(1):14499. PubMed ID: 37666951 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma. Li X; Xiao X; Chang R; Zhang C J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983 [TBL] [Abstract][Full Text] [Related]
10. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma. Wang P; Chen Y; Zheng Y; Fu Y; Ding Z Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369 [TBL] [Abstract][Full Text] [Related]
11. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. Zhang Z; Wang J; Han W; Zhao L BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma. Zhang J; Ling X; Fang C; Ma J Cell Mol Biol Lett; 2022 May; 27(1):39. PubMed ID: 35578166 [TBL] [Abstract][Full Text] [Related]
13. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing. Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043 [TBL] [Abstract][Full Text] [Related]
14. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
16. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Li J; Chen Z; Tian L; Zhou C; He MY; Gao Y; Wang S; Zhou F; Shi S; Feng X; Sun N; Liu Z; Skogerboe G; Dong J; Yao R; Zhao Y; Sun J; Zhang B; Yu Y; Shi X; Luo M; Shao K; Li N; Qiu B; Tan F; Chen R; He J Gut; 2014 Nov; 63(11):1700-10. PubMed ID: 24522499 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of long noncoding RNA ANRIL correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Cao T; Shen J; Pan W; Li C; Qiao Z J BUON; 2018; 23(6):1862-1866. PubMed ID: 30610814 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Zong MZ; Feng WT; Du N; Yu XJ; Yu WY Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448 [TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma. Meng X; Fang E; Zhao X; Feng J Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]